A detailed history of Los Angeles Capital Management LLC transactions in Generation Bio Co. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 295,727 shares of GBIO stock, worth $496,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares
295,727
Previous 341,861 13.49%
Holding current value
$496,821
Previous $964,000 24.27%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$2.16 - $3.51 $99,649 - $161,930
-46,134 Reduced 13.49%
295,727 $730,000
Q2 2024

Aug 05, 2024

SELL
$2.64 - $4.35 $105,072 - $173,130
-39,800 Reduced 10.43%
341,861 $964,000
Q1 2024

Apr 05, 2024

BUY
$1.73 - $4.07 $183,080 - $430,715
105,827 Added 38.37%
381,661 $1.55 Million
Q4 2023

Feb 06, 2024

BUY
$0.91 - $3.35 $190,610 - $701,697
209,462 Added 315.59%
275,834 $455,000
Q2 2023

Aug 03, 2023

BUY
$3.5 - $5.67 $7,700 - $12,474
2,200 Added 3.43%
66,372 $365,000
Q1 2023

May 04, 2023

SELL
$3.61 - $7.01 $4,187 - $8,131
-1,160 Reduced 1.78%
64,172 $275,000
Q2 2022

Aug 05, 2022

SELL
$4.87 - $9.41 $14,902 - $28,794
-3,060 Reduced 4.47%
65,332 $429,000
Q1 2022

May 06, 2022

BUY
$4.16 - $7.76 $196,031 - $365,674
47,123 Added 221.56%
68,392 $502,000
Q4 2021

Feb 03, 2022

SELL
$5.99 - $24.97 $257 - $1,073
-43 Reduced 0.2%
21,269 $151,000
Q3 2021

Nov 08, 2021

SELL
$20.0 - $27.43 $222,600 - $305,295
-11,130 Reduced 34.31%
21,312 $534,000
Q2 2021

Aug 05, 2021

SELL
$24.34 - $38.34 $8,519 - $13,419
-350 Reduced 1.07%
32,442 $873,000
Q1 2021

May 05, 2021

BUY
$24.74 - $40.2 $811,274 - $1.32 Million
32,792 New
32,792 $933,000

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $99.1M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.